| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cb5818fb4a0db960c7f6b7780fef110
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2d111a5041a7611bc662b3a09c228dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1b85129f8191c3e94194fb6c633f798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04be31be9f719f076eb2470cc15a1e4b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-88 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2014-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a84b2751e818195e88547914d23c7a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd488206d95912fdbd399b4666ef9b7c |
| publicationDate |
2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9181201-B2 |
| titleOfInvention |
Method of treatment of anxiety disorder comorbid with depression disorder |
| abstract |
The present invention relates to a method for treating comorbid anxiety disorders and depression disorders, as well as for preventing depression disorders in individuals affected by anxiety disorders, by administering a therapeutically effective amount of the compound of general formula (I): n n n n n n n n n n wherein R 1 is —OCH 3 or —CN n or suitable pharmaceutical salts, hydrates or anhydrates thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019113668-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021506796-A |
| priorityDate |
2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |